{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T06:34:48Z","timestamp":1764570888084,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.nmd.2019.11.011","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T13:12:07Z","timestamp":1574946727000},"page":"165-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["FHL1-related myopathy may not be classified by reducing bodies in muscle biopsy"],"prefix":"10.1016","volume":"30","author":[{"given":"Ting","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanqiang","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nmd.2019.11.011_bib0001","first-page":"904","article-title":"Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy","volume":"118","author":"Schessl","year":"2008","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.nmd.2019.11.011_bib0002","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2014.02.002","article-title":"199th ENMC international workshop: FHL1 related myopathies, June 7\u20139, 2013, naarden, the netherlands","volume":"24","author":"Bertrand A","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"Pt 2","key":"10.1016\/j.nmd.2019.11.011_bib0003","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/brain\/awn325","article-title":"Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1","volume":"132","author":"Schessl","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nmd.2019.11.011_bib0004","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ajhg.2007.09.013","article-title":"X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1","volume":"82","author":"Quinzii C","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.nmd.2019.11.011_bib0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajhg.2007.09.004","article-title":"An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1","volume":"82","author":"Windpassinger","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.nmd.2019.11.011_bib0006","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajhg.2009.07.015","article-title":"Mutations of the FHL1 gene cause Emery\u2013Dreifuss muscular dystrophy","volume":"85","author":"Gueneau","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"14","key":"10.1016\/j.nmd.2019.11.011_bib0007","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1093\/hmg\/dds157","article-title":"Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy","volume":"21","author":"Friedrich F","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.nmd.2019.11.011_bib0008","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.nmd.2013.02.006","article-title":"Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy","volume":"23","author":"Feldkirchner","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"10.1016\/j.nmd.2019.11.011_bib0009","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nmd.2011.05.007","article-title":"A study of FHL1, BAG3, MATR3, PTRF and TCAP in Australian muscular dystrophy patients","volume":"21","author":"Waddell L","year":"2011","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2019.11.011_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0030-1254101","article-title":"Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second lim domain mutation in FHL1","volume":"41","author":"Schessl","year":"2010","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2019.11.011_bib0011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fnagi.2014.00215","article-title":"Aggresome-Autophagy involvement in a sarcopenic patient with rigid spine syndrome and a p.C150R mutation in FHL1 gene","volume":"6","author":"Sabatelli","year":"2014","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1016\/j.nmd.2019.11.011_bib0012","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2001-17374","article-title":"Reducing body myopathy with cytoplasmic bodies and rigid spine syndrome: a mixed congenital myopathy","volume":"32","author":"Goebel H","year":"2001","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1016\/j.nmd.2019.11.011_bib0013","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/01.wnl.0000341311.84347.a0","article-title":"Novel FHL1 mutations in fatal and benign reducing body myopathy","volume":"72","author":"Shalaby","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2019.11.011_bib0014","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/ddy299","article-title":"Cardiomyopathy and altered integrin-actin signaling in FHL1 mutant female mice","volume":"28","author":"Kubota","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.nmd.2019.11.011_bib0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nmd.2018.03.001","article-title":"A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations","volume":"28","author":"Kessler","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2019.11.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.140905","article-title":"FHL1 mutations that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation","author":"Wilding B","year":"2014","journal-title":"J Cell Sci"},{"issue":"3","key":"10.1016\/j.nmd.2019.11.011_bib0017","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00401-003-0806-y","article-title":"Nucleolar characteristics of reducing bodies in reducing body myopathy","volume":"107","author":"Shinde","year":"2004","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nmd.2019.11.011_bib0018","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.braindev.2006.06.010","article-title":"Familial reducing body myopathy","volume":"29","author":"Ohsawa","year":"2007","journal-title":"Brain Dev"},{"issue":"9","key":"10.1016\/j.nmd.2019.11.011_bib0019","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/NEN.0b013e3182a23506","article-title":"Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders","volume":"72","author":"Malfatti","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2019.11.011_bib0020","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1212\/WNL.0b013e3181b2a4b3","article-title":"Consequences of mutations within the c terminus of the FHL1 gene","volume":"73","author":"Schoser","year":"2009","journal-title":"Neurology"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661931209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089661931209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:10Z","timestamp":1760774950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089661931209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S096089661931209X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2019.11.011","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FHL1-related myopathy may not be classified by reducing bodies in muscle biopsy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2019.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}